Sign Up to like & get recommendations! 0
Published in 2023 at "Klinische Monatsblatter fur Augenheilkunde"
DOI: 10.1055/a-1984-3660
Abstract: Despite the advent of a large variety of minimally invasive glaucoma surgery (MIGS) techniques cyclophotocoagulation (CPC) remains a popular treatment option to lower intraocular pressure (IOP) in glaucoma patients. Guidelines for glaucoma treatment point to… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Cornea"
DOI: 10.1097/ico.0000000000002064
Abstract: PURPOSE To evaluate the outcomes of transscleral cyclophotocoagulation (CPC) in the control of glaucoma in eyes with a Boston keratoprosthesis (KPro) type 1. METHODS This study is a retrospective case series of patients who have… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Current Opinion in Ophthalmology"
DOI: 10.1097/icu.0000000000000351
Abstract: Purpose of review There are currently various options available for glaucoma treatment procedures ranging from laser to penetrating to nonpenetrating surgeries. Innovations in glaucoma surgical therapeutics include features such as external application, focused tissue effects,… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Glaucoma"
DOI: 10.1097/ijg.0000000000000666
Abstract: Objective: To report the occurrence of 5 cases of Urrets-Zavalia syndrome after transscleral diode laser cyclophotocoagulation (TSCPC). Design: Retrospective cases series. Methods: A review of the charts of 5 patients treated with TSCPC as primary… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Glaucoma"
DOI: 10.1097/ijg.0000000000000757
Abstract: Purpose: To study and compare the outcome of micropulse transscelral cyclophotocoagulation in pediatric glaucoma patients to that in adult glaucoma patients. Methods: Consecutive pediatric and adult patients who received micropulse transscelral cyclophotocoagulation between July 2015… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Glaucoma"
DOI: 10.1097/ijg.0000000000001729
Abstract: PRECIS Micropulse trans-scleral cyclophotocoagulation is only moderately effective in lowering intraocular pressure and useful as an adjunct procedure to other glaucoma surgeries. There was a small risk of loss of vision, prolonged hypotony and phthisis… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "European Journal of Ophthalmology"
DOI: 10.1177/1120672119839303
Abstract: Purpose: To describe our clinical experience with the efficacy and safety of micropulse transscleral cyclophotocoagulation as a treatment for glaucoma. Methods: In this retrospective case series, we reviewed the charts of 95 consecutive patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_228_17
Abstract: We describe a case of a 13-year-old male patient of Coats' disease who developed sympathetic ophthalmia (SO) following contact diode laser cyclophotocoagulation. There was no history of invasive surgery or any perforating injuries preceding cyclodestructive… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_288_22
Abstract: Purpose: To determine the efficacy of subliminal cyclophotocoagulation in reducing intraocular pressure (IOP) and to assess the safety profile of the procedure. Methods: We reviewed the charts of all patients who underwent subliminal cyclophotocoagulation between… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Journal of Current Glaucoma Practice"
DOI: 10.5005/jp-journals-10078-1393
Abstract: Abstract Purpose To evaluate the effects of micropulse transscleral cyclophotocoagulation (mCPC) and selective laser trabeculoplasty (SLT) on endothelial cell density (ECD) and reduction of the intraocular pressure (IOP) in patients with primary-open angle glaucoma (POAG).… read more here.